CS logo
small CS logo
Istituto Ricerche Farmacologiche Mario Negri IRCCS

Bergamo, Lombardia, Italy
Research institute in Milan
Via Mario Negri, 2, 20156 Milano MI

About Istituto Ricerche Farmacologiche Mario Negri IRCCS


"L'Istituto di Ricerche Farmacologiche Mario Negri IRCCS è un'organizzazione scientifica che opera nel campo della ricerca biomedica."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Bayer
3
Mario Negri Institute for Pharmacological Research
3
Imperial College London
1
Total Rows: 3

Clinical Trials at Istituto Ricerche Farmacologiche Mario Negri IRCCS


During the past decade, Istituto Ricerche Farmacologiche Mario Negri IRCCS conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22001111330000000011Started TrialsCompleted Trails2017201820192020202101234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Decision-aid on Breast Cancer Screening
2017-09-01
2019-04-30
Completed
1,001
Developing and Validating Blood and Imaging BIOmarkers of AXonal Injury Following Traumatic Brain Injury
2017-11-30
2021-12-30
Completed
313
NASCITA Italian Birth Cohort Study
2019-04-01
2026-04-01
Active, not recruiting
5,000
Study on the Safety of the Drug Runcaciguat and How Well it Works When Given at the Highest Dose as Tolerated by Individual Patient Whose Kidneys Are Not Working Properly and Suffering at the Same Time From High Blood Sugar and/or High Blood Pressure and a Disease of the Heart and the Blood Vessels.
2020-09-01
2022-04-05
Completed
243
Health-care Quality in Semi-intensive Care Units
2021-07-01
2025-12-01
Recruiting
39,000
An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants
2021-08-18
2021-12-31
Completed
951
A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease
2021-09-21
2026-02-09
Recruiting
1,580

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Ricerche Farmacologiche Mario Negri IRCCS" #1 collaborator was "Centre Hospitalier Universitaire Vaudois" with 1 trials as a collaborator, "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico" with 1 trials as a collaborator, "Istituto Di Ricerche Farmacologiche Mario Negri" with 1 trials as a collaborator and "University College, London" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Istituto Ricerche Farmacologiche Mario Negri IRCCS


According to Clinical.Site data, the most researched conditions in "Istituto Ricerche Farmacologiche Mario Negri IRCCS" are "Chronic Kidney Disease" (2 trials), "Breast Cancer" (1 trials), "Communicable Diseases" (1 trials), "Development, Child" (1 trials) and "Evaluation" (1 trials). Many other conditions were trialed in "Istituto Ricerche Farmacologiche Mario Negri IRCCS" in a lesser frequency.

Clinical Trials Intervention Types at Istituto Ricerche Farmacologiche Mario Negri IRCCS


Most popular intervention types in "Istituto Ricerche Farmacologiche Mario Negri IRCCS" are "Drug" (3 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Blood Sampling" (1 trials), "Decision-aid" (1 trials), "Finerenone (BAY94-8862)" (1 trials) and "Finerenone (Kerendia, BAY94-8862)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Istituto Ricerche Farmacologiche Mario Negri IRCCS


The vast majority of trials in "Istituto Ricerche Farmacologiche Mario Negri IRCCS" are 6 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Istituto Ricerche Farmacologiche Mario Negri IRCCS


Currently, there are NaN active trials in "Istituto Ricerche Farmacologiche Mario Negri IRCCS". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Istituto Ricerche Farmacologiche Mario Negri IRCCS, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Istituto Ricerche Farmacologiche Mario Negri IRCCS, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status

Departments of Istituto Ricerche Farmacologiche Mario Negri IRCCS


Istituto Ricerche Farmacologiche Mario Negri IRCCS has several departments that took part in Clinical trials: "Clinical Research Center for Rare Diseases" - 16 trials, "Clinical Research Center for Rare Diseases "Aldo e Cele Daccò"" - 4 trials, "Mario Negri Institute for Pharmacological Research" - 2 trials